Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference

BOULDER, Colo., Dec. 1, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Array BioPharma.



Oppenheimer Annual Healthcare Conference


Ron Squarer, Chief Executive Officer


Wednesday, December 9, 2015


10:20 a.m. Eastern Time



About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to



Tricia Haugeto

Array BioPharma Inc.



Logo -


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.

Back to news